MA22926A1 - Procede pour la preparation de nouveaux composes. - Google Patents

Procede pour la preparation de nouveaux composes.

Info

Publication number
MA22926A1
MA22926A1 MA23216A MA23216A MA22926A1 MA 22926 A1 MA22926 A1 MA 22926A1 MA 23216 A MA23216 A MA 23216A MA 23216 A MA23216 A MA 23216A MA 22926 A1 MA22926 A1 MA 22926A1
Authority
MA
Morocco
Prior art keywords
preparation
new compounds
pct
sec
date jun
Prior art date
Application number
MA23216A
Other languages
English (en)
Inventor
A Daines Robert
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MA22926A1 publication Critical patent/MA22926A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA23216A 1992-06-30 1993-06-28 Procede pour la preparation de nouveaux composes. MA22926A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90677192A 1992-06-30 1992-06-30
US2519893A 1993-03-02 1993-03-02

Publications (1)

Publication Number Publication Date
MA22926A1 true MA22926A1 (fr) 1994-04-01

Family

ID=26699422

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23216A MA22926A1 (fr) 1992-06-30 1993-06-28 Procede pour la preparation de nouveaux composes.

Country Status (16)

Country Link
US (1) US5990314A (fr)
EP (1) EP0649412B1 (fr)
JP (1) JP3230682B2 (fr)
KR (1) KR950702185A (fr)
CN (1) CN1108247A (fr)
AT (1) ATE231129T1 (fr)
AU (2) AU4545893A (fr)
CA (1) CA2138954A1 (fr)
DE (1) DE69332640T2 (fr)
ES (1) ES2191014T3 (fr)
IL (1) IL106156A0 (fr)
MA (1) MA22926A1 (fr)
MX (1) MX9303973A (fr)
NZ (1) NZ253967A (fr)
SI (1) SI9300349A (fr)
WO (1) WO1994000437A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0711282B1 (fr) 1993-07-28 2002-06-05 Aventis Pharma Limited Composes utilises comme inhibiteurs de pde iv et du facteur de necrose tumorale (tnf)
JPH09506367A (ja) * 1993-12-08 1997-06-24 スミスクライン・ビーチャム・コーポレイション 化合物
NZ278484A (en) * 1993-12-09 1998-02-26 Smithkline Beecham Corp Diphenyl-2-propenoates and homologues; medicaments
EP0812194B1 (fr) * 1995-03-02 2000-08-16 Smithkline Beecham Corporation Utilisation de composés substitués de pyridine pour le traitement de l'eczema constitutionel et de l'eczema de contact
GB9508137D0 (en) * 1995-04-21 1995-06-07 Smithkline Beecham Plc Formulation
GB9602675D0 (en) * 1996-02-09 1996-04-10 Smithkline Beecham Plc Process
US5929096A (en) * 1996-02-29 1999-07-27 Smithkline Beecham Corporation Method for treating atopic dermatitis and contact dermatitis
AU4557397A (en) * 1996-09-26 1998-04-17 Novartis Ag Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity
US7361671B2 (en) * 2001-11-15 2008-04-22 The Institute For Pharmaceutical Discovery, Inc. Substituted heteroarylalkanoic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT64747A (en) * 1990-06-07 1994-02-28 Smithkline Beecham Corp Process for producing benzoic acid derivatives and pharmaceutical preparatives containing them
HUT64748A (en) * 1990-06-07 1994-02-28 Smithkline Beecham Corp Method for producing benzoic acid derivatives and pharmaceutical preparatives containing said compounds
US5643914A (en) * 1993-03-02 1997-07-01 Smithkline Beecham Corporation Pharmaceutical pyridine compounds

Also Published As

Publication number Publication date
ATE231129T1 (de) 2003-02-15
IL106156A0 (en) 1993-10-20
EP0649412A1 (fr) 1995-04-26
MX9303973A (es) 1994-04-29
KR950702185A (ko) 1995-06-19
JPH07508284A (ja) 1995-09-14
NZ253967A (en) 1996-11-26
SI9300349A (sl) 1993-12-31
WO1994000437A1 (fr) 1994-01-06
CN1108247A (zh) 1995-09-13
JP3230682B2 (ja) 2001-11-19
US5990314A (en) 1999-11-23
EP0649412B1 (fr) 2003-01-15
EP0649412A4 (fr) 1995-07-05
AU2280797A (en) 1997-08-14
AU4545893A (en) 1994-01-24
AU707102B2 (en) 1999-07-01
ES2191014T3 (es) 2003-09-01
DE69332640T2 (de) 2003-11-06
DE69332640D1 (de) 2003-02-20
CA2138954A1 (fr) 1994-01-06

Similar Documents

Publication Publication Date Title
MA19639A1 (fr) Procede de preparation de derives de l'acide cis, endo-2-azabicyclo- (3,3,0) -octane-3- carboxylique et d'agents contenant ces derives
MA22668A1 (fr) Procede de preparation d'oxamides .
MA22896A1 (fr) Procede de production de n-aryl- et n-heteroarylurees utilisables comme inhibiteurs d'acylcoenzymes a:cholesterol-acyltransferase (acat) .
RO89143A (fr) Procede pour la preparation des derives d'acyloxypurines substitues
MA24158A1 (fr) Derives d'imidazole substitues, procede pour leur preparation et compositions les contenant
ES2132415T3 (es) Nuevos derivados de 5-pirrolil-2-piridilmetilsulfinilbencimidazol.
PT97602A (pt) Processo para a preparacao de indolonas neuroprotectoras e de derivados relacionados com as mesmas
ES2081000T3 (es) Derivados de hidantoina.
FR2569691B1 (fr) Derives de benzimidazole, procede pour les preparer et agents anti-ulcereux les contenant
OA09364A (fr) "Composition fongicide pour traitement de semences".
MA22176A1 (fr) Procede pour l'obtention des compositions antimalariales
MA22906A1 (fr) Derives nouveaux de pyrazole substitues sur l'azote, leur procede de production, compositions les contenant et leur utilisation comme herbicides.
MA22926A1 (fr) Procede pour la preparation de nouveaux composes.
ZA961364B (en) 1-Aryl-2-acylamino-ethane compounds
FR2569702B1 (fr) Nouvelle 4'-deschlororebeccamycine, composition pharmaceutique la contenant et procede pour sa preparation
MA21902A1 (fr) Procede pour la preparation de peptitides hemoregulateurs et des compositions pharmaceutiques les comtenant .
FR2557108B1 (fr) 5-pyrimidinecarboxamide ou thiocarboxamide, composition pharmaceutique pour induire la regression de la leucemie et l'inhibition de la croissance des tumeurs le contenant, procede de production de 5-pyrimidinecarboxamide ou thiocarboxamide et procede pour induire la regression de la leucemie et l'inhibition de la croissance des tumeurs en l'utilisant
IT1171624B (it) Indolinoni dotati di proprieta' farmaceutiche e procedimento per la loro produzione
PT85948A (fr) Procede pour la preparation de derives d'imidazole et de compositions regulatrices de la croissance des plantes qui les conti ennent
FR2630888B1 (fr) Procede pour augmenter la productivite des truies
FR2573762B1 (fr) Derives 4-hydroxyphenylthioalkyliques substitues, compositions les contenant et leur procede d'emploi
RO85812A (fr) Procede pour la preparation des derives d'azolylpentene
FR2670198B1 (fr) Composition pour la desinfection de l'eau par le procede d'electrochloration et utilisation de cette composition.
FR2647446B1 (fr) Procede pour la preparation selective de 1,4-diamino-2-nitrobenzenes substitues en n4
FR2673635B1 (fr) Procede pour la preparation d'une composition aerosol.